BPI protein (Bridge BioResearch)

N/A

Report date: 2023/02/04 20:00:59

Base Information

Drug NameBPI protein (Bridge BioResearch)
Drug Alias NameBPI protein (type 2 diabetes)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBridge Bioresearch Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBridge Bioresearch Ltd
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A